Opioid Use Clinical Trial
Official title:
Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Verified date | April 2024 |
Source | Masimo Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This Clinical Trial will evaluate the Feasibility and Acceptability of Oxygen Saturation Monitoring using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Status | Terminated |
Enrollment | 10 |
Est. completion date | February 15, 2024 |
Est. primary completion date | February 15, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria for Client Participants: - Participants who are18 years of age or greater - Participants housed within a supportive housing program who intend to inject opioids - Participants who have given verbal informed consent to participate in the study Inclusion Criteria for Staff Participants: - Participant is research staff and/or Rita Thompson Residence staff - Participant is willing to give implied consent by reading and completing the staff survey Exclusion Criteria for Client Participants: - Participants deemed not suitable for the study at the discretion of the principal investigator, research staff or housing program nurses/staff - Participants with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as psoriasis, eczema, angioma, burns, scar tissue, substantial skin breakdown, nail polish, acrylic nails, infections, or other abnormalities that may interfere with MSNA functioning - Participants with known allergic reactions to foam/rubber products and/or adhesive tape Exclusion Criteria for Staff Participants: -None |
Country | Name | City | State |
---|---|---|---|
Canada | Research Site | Vanier |
Lead Sponsor | Collaborator |
---|---|
Masimo Corporation |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing the recruitment rate to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing proportion of incomplete studies to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing proportion of lost components to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing the recruitment rate to evaluate the acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing the proportion of incomplete studies to evaluate the acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program | Summarizing the proportion of lost components to evaluate the acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program. | 2-4 weeks | |
Primary | Evaluation of integration and expansion of Masimo SafetyNet Alert (MSNA) to similar housing environments | Summarizing the recruitment rate to evaluate the integration and expansion of Masimo SafetyNet Alert (MSNA) to similar housing environments. | 2-4 weeks | |
Primary | Evaluation of integration and expansion of Masimo SafetyNet Alert (MSNA) to similar housing environments | Summarizing the proportion of incomplete studies to evaluate the integration and expansion of Masimo SafetyNet Alert (MSNA) to similar housing environments. | 2-4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04095624 -
Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion
|
N/A | |
Completed |
NCT04484610 -
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
|
Phase 4 | |
Recruiting |
NCT04598074 -
Opioid Package Prototype (OPP)
|
N/A | |
Recruiting |
NCT06033599 -
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
|
Phase 3 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Completed |
NCT05845177 -
Persistent Pain After Hip Replacement
|
||
Completed |
NCT03570320 -
Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
Completed |
NCT05593341 -
Opioid Education in Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT06055205 -
A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries
|
N/A | |
Recruiting |
NCT05877157 -
Pain AND Opioids After Surgery
|
||
Recruiting |
NCT03675386 -
Reducing Opioid Use for Chronic Pain Patients Following Surgery
|
N/A | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT04868552 -
Naloxone Education in Total Joint Patients
|
N/A | |
Completed |
NCT03540030 -
Opioid-Free Shoulder Arthroplasty
|
Phase 4 | |
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03545516 -
Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery
|
Phase 2 | |
Terminated |
NCT03426137 -
Relieving Acute Pain (RAP) Study: A Pilot Study
|
Phase 2 |